Pulmonary Sarcoidosis: Prognostic Factors at Diagnosis in Patients from North of Portugal

Valeyre, 2014, Sarcoidosis, Lancet, 383, 1155, 10.1016/S0140-6736(13)60680-7 Bargagli, 2008, Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas, Clin Chest Med, 29, 445, 10.1016/j.ccm.2008.03.004 Zissel, 2014, Cellular activation in the immune response of sarcoidosis, Semin Respir Crit Care Med, 35, 307, 10.1055/s-0034-1376861 Judson, 2007, Extrapulmonary sarcoidosis, Semin Respir Crit Care Med, 28, 83, 10.1055/s-2007-970335 Baughman, 2011, A concise review of pulmonary sarcoidosis, Am J Respir Crit Care Med, 183, 573, 10.1164/rccm.201006-0865CI Doubkova, 2015, Prognostic markers of sarcoidosis: an analysis of patients from everyday pneumological practice, Clin Respir J, 9, 443, 10.1111/crj.12160 Hunninghake, 1999, ATS/ERS/WASOG statement on sarcoidosis American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders, Sarcoidosis Vasc Diffuse Lung Dis, 16, 149 Kollert, 2011, The impact of gas exchange measurement during exercise in pulmonary sarcoidosis, Respir Med, 105, 122, 10.1016/j.rmed.2010.09.007 Danila, 2009, BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity, Ups J Med Sci, 114, 26, 10.1080/03009730802579729 Sharma, 2008, Sarcoidosis around the world, Clin Chest Med, 29, 357, 10.1016/j.ccm.2008.03.013 Cardoso, 2017, Analysis of sarcoidosis in the Oporto region (Portugal), Rev Port Pneumol, 23, 251 Wasfi, 2006, A new tool to assess sarcoidosis severity, Chest, 129, 1234, 10.1378/chest.129.5.1234 Wahlström, 2001, Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis, Am J Respir Crit Care Med, 163, 115, 10.1164/ajrccm.163.1.9906071 Scadding, 1961, Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation, Br Med J, 2, 1165, 10.1136/bmj.2.5261.1165 Tejera Segura, 2014, [Löfgren syndrome: a study of 80 cases], Med Clin (Barc), 143, 166, 10.1016/j.medcli.2014.02.029 Judson, 2003, ACCESS Research Group. Two-year prognosis of Sarcoidosis: the ACCESS experience, Sarcoidosis Vasc Diffuse Lung Dis, 20, 204 Morais, 2008, HLA class I and II and TNF-alpha gene polymorphisms in sarcoidosis patients, Rev Port Pneumol, 14, 727, 10.1016/S0873-2159(15)30284-1 Morais, 2012, BTNL2 gene polymorphism associations with susceptibility and phenotype expression in sarcoidosis, Respir Med, 106, 1771, 10.1016/j.rmed.2012.08.009 Morais, 2013, Annexin A11 gene polymorphism (R230C variant) and sarcoidosis in a Portuguese population, Tissue Antigens, 82, 186, 10.1111/tan.12188 Neville, 1983, Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients, Q J Med, 52, 525 Mañá, 2017, Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain, Medicine, 96, e7595, 10.1097/MD.0000000000007595 Drent, 2012, Sarcoidosis-associated fatigue, Eur Respir J, 40, 255, 10.1183/09031936.00002512 Peros-Golubičić, 2001, Lung lavage neutrophils. Neutrophil elastase and albumin in the prognosis of pulmonary sarcoidosis, Coll Antropol, 25, 349 Gibson, 1996, British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment, Thorax, 51, 238, 10.1136/thx.51.3.238 Nagai, 2008, Outcome of sarcoidosis, Clin Chest Med, 29, 565, 10.1016/j.ccm.2008.03.006 Meyer, 2011, Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?, Eur Respir J, 38, 761, 10.1183/09031936.00069509 Judson, 2008, The diagnosis of sarcoidosis, Clin Chest Med, 29, 415, 10.1016/j.ccm.2008.03.009 Meyer, 2012, American Thoracic Society Committee on BAL in Interstitial Lung Disease. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease, Am J Respir Crit Care Med, 185, 1004, 10.1164/rccm.201202-0320ST Hattori, 2017, Resolution rate of pulmonary sarcoidosis and its related factors in a Japanese population, Respirology, 22, 1604, 10.1111/resp.13105